Ava Stanley1, Derek DeLia, Joel C Cantor. 1. Center for State Health Policy, Rutgers University, 55 Commercial Ave., Third Floor, New Brunswick, NJ 08901, USA.
Abstract
BACKGROUND: Although implantable cardioverter defibrillator (ICD) therapy is widely endorsed for preventing sudden cardiac death (SCD), prior research documented a large black-white disparity in ICD therapy among the elderly. No studies have examined this disparity among nonelderly adults or over time as ICD therapy became widely diffused. OBJECTIVE: This study compares disparity in use of ICD therapy for 1996-1998 to 1999-2001 between African Americans and other adults. METHODS: The National Hospital Discharge Survey is used to compare ICD utilization between black and other adults diagnosed with ventricular tachycardia, ventricular fibrillation or cardiac arrest. RESULTS: Adjusting for patient and hospital characteristics, ICD use per 100 at-risk patients rose from 11.0 to 27.3 among African Americans and from 24.0 to 37.5 among other adults between 1996-1998 and 1999-2001. Although the disparity was evident throughout the study period, it declined by 40%. Compared with their nonblack counterparts, black adults at risk for SCD were five years younger on average (p < 0.01) and more likely to be female (p < 0.01). CONCLUSIONS: As ICD therapy became more widely available, use of this technology increased faster for black versus other adults, and the disparity in use declined but was not eliminated. Policymakers and clinicians should focus on increasing access among underserved populations to promising new technologies. Research focusing only on the elderly may miss important racial disparities when there is a race difference in the age distribution of disease risk. Further research should explore the relationship of technology diffusion to disparities in health service use.
BACKGROUND: Although implantable cardioverter defibrillator (ICD) therapy is widely endorsed for preventing sudden cardiac death (SCD), prior research documented a large black-white disparity in ICD therapy among the elderly. No studies have examined this disparity among nonelderly adults or over time as ICD therapy became widely diffused. OBJECTIVE: This study compares disparity in use of ICD therapy for 1996-1998 to 1999-2001 between African Americans and other adults. METHODS: The National Hospital Discharge Survey is used to compare ICD utilization between black and other adults diagnosed with ventricular tachycardia, ventricular fibrillation or cardiac arrest. RESULTS: Adjusting for patient and hospital characteristics, ICD use per 100 at-risk patients rose from 11.0 to 27.3 among African Americans and from 24.0 to 37.5 among other adults between 1996-1998 and 1999-2001. Although the disparity was evident throughout the study period, it declined by 40%. Compared with their nonblack counterparts, black adults at risk for SCD were five years younger on average (p < 0.01) and more likely to be female (p < 0.01). CONCLUSIONS: As ICD therapy became more widely available, use of this technology increased faster for black versus other adults, and the disparity in use declined but was not eliminated. Policymakers and clinicians should focus on increasing access among underserved populations to promising new technologies. Research focusing only on the elderly may miss important racial disparities when there is a race difference in the age distribution of disease risk. Further research should explore the relationship of technology diffusion to disparities in health service use.
Authors: Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; Gabriel Gregoratos; Loren F Hiratzka; David P Faxon; Alice K Jacobs; Valentin Fuster; Sidney C Smith Journal: Circulation Date: 2002-10-15 Impact factor: 29.690
Authors: Mark Alexander; Laurence Baker; Cheryl Clark; Kathryn M McDonald; Richard Rowell; Olga Saynina; Mark A Hlatky Journal: Am Heart J Date: 2002-09 Impact factor: 4.749
Authors: Anne Marie McCarthy; Philip Yamartino; Jianing Yang; Mirar Bristol; Emily F Conant; Katrina Armstrong Journal: Med Care Date: 2015-08 Impact factor: 2.983
Authors: Tracy Onega; Tor D Tosteson; Qianfei Wang; Bruce E Hillner; Yunjie Song; Barry A Siegel; Anna N A Tosteson Journal: J Am Coll Radiol Date: 2012-09 Impact factor: 5.532
Authors: Ragnar Westerling; Marcus Westin; Martin McKee; Rasmus Hoffmann; Iris Plug; Grégoire Rey; Eric Jougla; Katrin Lang; Kersti Pärna; José L Alfonso; Johan P Mackenbach Journal: J Eval Clin Pract Date: 2014-04-22 Impact factor: 2.431
Authors: Daniel Weiss; Håvard T Rydland; Emil Øversveen; Magnus Rom Jensen; Solvor Solhaug; Steinar Krokstad Journal: PLoS One Date: 2018-04-03 Impact factor: 3.240